Microbix Biosystms (TSE:MBX) has released an update.
Microbix Biosystems Inc. has successfully obtained critical EU regulatory accreditations, meeting the EU In Vitro Diagnostics Regulation and receiving CE Certification for 11 of its REDx Quality Assessment Products (QAPs). This development allows Microbix full access to EU-regulated markets and enhances its capability to support the quality management needs of clinical labs across Europe. The certifications confirm the company’s commitment to safety, efficacy, and product consistency in the life sciences sector.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
